Page 6 - போர்த ஹவாஸ் சர்வதேச நிதி தகவல்தொடர்புகள் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from போர்த ஹவாஸ் சர்வதேச நிதி தகவல்தொடர்புகள் குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In போர்த ஹவாஸ் சர்வதேச நிதி தகவல்தொடர்புகள் குழு Today - Breaking & Trending Today

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China .
Apollomics, Inc.February 12, 2021 GMT
FOSTER CITY, Calif. and HANGZHOU, ZHEJIANG, China, Feb. 12, 2021 (GLOBE NEWSWIRE) Apollomics, Inc., an innovative biopharmaceutical company committed to the discovery and development of mono- and combination- oncology therapies, today announced an exclusive license agreement for the development and commercialization of TYG100 in Mainland China, Hong Kong, Macau and Taiwan, also known as Greater China, and South Africa.
TYG100 is an antigen-specific, active checkpoint control immunotherapy (ACCI) recombinant vaccine comprising the amino-terminal sequence of G17, a gastrointestinal peptide hormone, and utilizes the S-TIR™ technology platform. This technology induces a novel mechanism of action that is able to unmask tumors. TYG100 was ....

Jian Ni , Hong Kong , United Kingdom , South Africa , Remy Bernarda , Guo Liang Yu , Fred Jacobs , Kelly Fung , Wilsonw Cheung , Porda Havas International Finance Communications Group , Cancer Research United Kingdom , Corporate Communications , Apollomics Inc , Mainland China , Greater China , Cancer Research United , Nuance Biotech , Chief Executive Officer , Media Contact , Licensing Agreements , Corporate News , Pharmaceutical Manufacturing , Health Care Industry , East Asia , Diseases And Conditions , Globe Newswire ,